ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

USFDA pulls up Natco Pharma for several violations at Telangana plant
Natco Pharma failed to maintain cleanliness, sterilise equipment and utensils at appropriate intervals at its Telangana-based plant, as per the US health regulator. In the warning letter to the company, US Food and Drug Administration said its investigator
Announcement as on 21 April 2024

USFDA pulls up Natco Pharma for manufacturing lapses at Telangana plant
Natco Pharma's Telangana plant violated cleanliness and sterilisation standards at Kothur Village facility per USFDA. The warning letter mentioned cross-contamination, inadequate cleaning procedures, and the need for comprehensive investigations and correc
Announcement as on 21 April 2024

Complaint filed against Natco Pharma in US by Fresenius Kabi
Natco Pharma faces a legal complaint from Fresenius Kabi in the US District Court regarding the marketing of Diazepam injection prefilled syringe. Fresenius Kabi USA, LLC and Fresenius Kabi Deutschland GmbH filed the complaint against Natco Pharma USA LLC
Announcement as on 18 April 2024

Natco Pharma receives warning letter from USFDA for Telangana plant
Natco Pharma on Tuesday said it has received a warning letter from the US health regulator for its Telangana-based manufacturing plant. The US Food and Drug Administration (USFDA) had issued eight observations under Form 483 after inspecting the company's
Announcement as on 09 April 2024

Natco Pharma gets warning letter from USFDA for Telangana plant
Natco Pharma, a pharmaceutical company, received a warning letter from the USFDA regarding its manufacturing plant in Telangana. This came after the FDA conducted an inspection of the company's facility in Kothur last October, issuing eight observations un
Announcement as on 09 April 2024

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 898.71
  • 12Day Average: 878.18
  • 20Day Average: 887.4
  • 50Day Average: 1034.98
  • 100Day Average: 991.45
  • 150Day Average: 956.28
  • 200Day Average: 925.23

524816 Indicators & signals

Indicator MACD (12,26,9)

898.95, 939.39, -52.41
Indicator MACD is in negative zone

Indicator ADX (14)

7.59, 20.4, 23.75
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 39
Indicator RSI is indicating selling pressure and stock might fall.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
29 Mon Jun 2026 918.85 890.50 to 924.00 1.7% 0.67 times
25 Thu Jun 2026 903.45 894.95 to 918.10 1.06% 1.53 times
24 Wed Jun 2026 893.95 890.00 to 913.35 0.11% 0.99 times
23 Tue Jun 2026 892.95 885.25 to 913.00 0.97% 1.91 times
22 Mon Jun 2026 884.35 881.80 to 892.75 -0.5% 0.21 times
19 Fri Jun 2026 888.75 877.00 to 909.00 0.62% 0.58 times
18 Thu Jun 2026 883.25 862.80 to 895.80 1.86% 1.59 times
17 Wed Jun 2026 867.10 844.05 to 869.00 1.83% 0.96 times
16 Tue Jun 2026 851.55 841.50 to 858.25 0.47% 0.32 times
15 Mon Jun 2026 847.55 839.80 to 888.95 -1.89% 1.13 times
12 Fri Jun 2026 863.85 849.75 to 866.00 2.53% 0.78 times
11 Thu Jun 2026 842.55 839.35 to 874.90 -1.46% 1.24 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top